Johnson & Johnson quarterly sales rise 12.6 percent
(Reuters) - Healthcare conglomerate Johnson & Johnson on Tuesday posted a 12.6 percent rise in quarterly sales, helped by strong demand for its cancer drugs.
Johnson & Johnson quarterly sales rise 12.6 percent Read More
0 Response to "Johnson & Johnson quarterly sales rise 12.6 percent"
Posting Komentar